Event Abstract Back to Event Glucose deprivation increases monocarboxylate transporter 1 (MCT1) expression and MCT1-dependent tumor cell migration Paolo E. Porporato1, Christophe J. De Saedeleer1, Tamara Copetti1, Jhudit Pérez-Escuredo1, Valéry L. Payen1, Lucie Brisson1, Olivier Feron1 and Pierre Sonveaux1* 1 Université catholique de Louvain (UCL), Institut de Recherche Expérimentale et Clinique (IREC), Belgium Background and aim. The glycolytic end-product lactate is a pleiotropic tumor growth-promoting factor. Its activities primarily depend on its uptake, a process facilitated by the lactate-proton symporter monocarboxylate transporter 1 (MCT1). Therefore, targeting the transporter or its chaperon protein CD147/basigin, itself involved in the aggressive malignant phenotype, is an attractive therapeutic option for cancer, but basic information is still lacking regarding the regulation of the expression, interaction and activities of both proteins in tumors. Methods. Oxidative human cervix cancer SiHa and HeLa cells that express both MCT1 and CD147 were chosen as main cellular models. MCT1 and CD147 mRNA and protein levels were measured after different treatments ranging from glucose deprivation to mitochondrial oxygen consumption impairment. Protein interaction was tested using proximity ligation. Cell migration was assayed in transwells with different chemoattractants, also using tumor cells overexpressing MCT1 or CD147, or infected with specific shRNAs. Results. We found that glucose withdrawal dose-dependently upregulates MCT1 and CD147 protein expression and their interaction in oxidative tumor cells. While this transcription-independent induction could be recapitulated using glycolysis inhibition, hypoxia, the mitochondrial complex I inhibitor rotenone or hydrogen peroxide, it was blocked with alternative oxidative substrates and specific antioxidants, pointing out at a mitochondrial control. Indeed, we found that the stabilization of MCT1 and CD147 proteins upon glucose removal depends on mitochondrial impairment and the associated generation of reactive oxygen species. When glucose was a limited resource (a situation occurring naturally or during the treatment of many tumors), MCT1-CD147 heterocomplexes formed preferentially in cell protrusions. It endowed oxidative tumor cells with increased migratory capacities towards glucose. Migration was inhibited by providing an alternative oxidative fuel to glucose-starved cells or by targeting MCT1 using RNA interference or pharmacological inhibition. Conclusion. While our study identifies the mitochondrion as a glucose sensor promoting tumor cell migration, MCT1 is also revealed as a transducer of this response, providing a new rationale for the use of MCT1 inhibitors in cancer. Acknowledgements This work was supported by ERC Starting Grant 243188 TUMETABO to Pierre Sonveaux. Keywords: mct1, Basigin/CD147, Cancer, tumor metabolism, cell migration, Mitochondria, Reactive Oxygen Species Conference: 4th Annual Meeting of the International Society of Proton Dynamics in Cancer, Garching, Germany, 10 Oct - 12 Oct, 2013. Presentation Type: Abstract Topic: 3. pH, cell signalling and growth Citation: Porporato PE, De Saedeleer CJ, Copetti T, Pérez-Escuredo J, Payen VL, Brisson L, Feron O and Sonveaux P (2014). Glucose deprivation increases monocarboxylate transporter 1 (MCT1) expression and MCT1-dependent tumor cell migration. Front. Pharmacol. Conference Abstract: 4th Annual Meeting of the International Society of Proton Dynamics in Cancer. doi: 10.3389/conf.fphar.2014.61.00039 Copyright: The abstracts in this collection have not been subject to any Frontiers peer review or checks, and are not endorsed by Frontiers. They are made available through the Frontiers publishing platform as a service to conference organizers and presenters. The copyright in the individual abstracts is owned by the author of each abstract or his/her employer unless otherwise stated. Each abstract, as well as the collection of abstracts, are published under a Creative Commons CC-BY 4.0 (attribution) licence (https://creativecommons.org/licenses/by/4.0/) and may thus be reproduced, translated, adapted and be the subject of derivative works provided the authors and Frontiers are attributed. For Frontiers’ terms and conditions please see https://www.frontiersin.org/legal/terms-and-conditions. Received: 16 Dec 2013; Published Online: 07 Feb 2014. * Correspondence: Prof. Pierre Sonveaux, Université catholique de Louvain (UCL), Institut de Recherche Expérimentale et Clinique (IREC), Brussels, 1200, Belgium, pierre.sonveaux@uclouvain.be Login Required This action requires you to be registered with Frontiers and logged in. To register or login click here. Abstract Info Abstract The Authors in Frontiers Paolo E Porporato Christophe J De Saedeleer Tamara Copetti Jhudit Pérez-Escuredo Valéry L Payen Lucie Brisson Olivier Feron Pierre Sonveaux Google Paolo E Porporato Christophe J De Saedeleer Tamara Copetti Jhudit Pérez-Escuredo Valéry L Payen Lucie Brisson Olivier Feron Pierre Sonveaux Google Scholar Paolo E Porporato Christophe J De Saedeleer Tamara Copetti Jhudit Pérez-Escuredo Valéry L Payen Lucie Brisson Olivier Feron Pierre Sonveaux PubMed Paolo E Porporato Christophe J De Saedeleer Tamara Copetti Jhudit Pérez-Escuredo Valéry L Payen Lucie Brisson Olivier Feron Pierre Sonveaux Related Article in Frontiers Google Scholar PubMed Abstract Close Back to top Javascript is disabled. Please enable Javascript in your browser settings in order to see all the content on this page.
Read full abstract